A Safety and Efficacy Study of a New Eye Drop Formulation in Patients With Dry Eye Disease
| Status: | Completed |
|---|---|
| Conditions: | Ocular |
| Therapuetic Areas: | Ophthalmology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 3/16/2015 |
| Start Date: | October 2014 |
| End Date: | June 2015 |
| Contact: | Allergan Inc. |
| Email: | clinicaltrials@allergan.com |
This study will evaluate the safety and efficacy of a new eye drop formulation in patients
with dry eye disease.
with dry eye disease.
Inclusion Criteria:
- Current use of an artificial tear product
- Visual acuity of at least 20/32 (while wearing glasses, if necessary).
Exclusion Criteria:
- Use of contact lenses in the last 3 months, or anticipated use of contact lenses
during the study
- Cataract surgery, laser-assisted in situ keratomileusis [LASIK], or photorefractive
keratectomy, within the last 6 months
- Current eye infection or inflammation
We found this trial at
2
sites
Click here to add this to my saved trials
Click here to add this to my saved trials